The AVONELLE-X study confirms sustained visual gains and treatment durability of faricimab for wet AMD over four years. 80% ...

The ACTOR study finds OCT angiography cannot predict exudative recurrence in neovascular AMD but offers valuable vascular ...

Following the assembly of the prototype, the OCT researchers were able to present the first high-resolution images of the eye ...

Kala Bio announced that CHASE (NCT05727878), its phase 2b clinical trial of KPI-012 for persistent corneal epithelial defect ...

Explore the Fight Retinal Blindness! Project, a global registry enhancing VEGF inhibitor treatment outcomes with ...

Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to ...

The US Food and Drug Administration (FDA) has approved Amneal Pharmaceuticals' Abbreviated New Drug Application (ANDA) for ...

A study of the effects of repetitive impacts to the head during one season of football found that the smooth pursuit velocity ...

Their answers reflect the diversity of challenges facing ophthalmologists today, from the most common causes of vision loss ...

“Pattern recognition is key,” emphasized Prem S. Subramanian, MD, PhD, as he discussed the challenges of distinguishing ...

Can you share some highlights from the BETTER study with us? Marion Munk, MD, PhD: I'm very excited about this project. We ...

The US Food and Drug Administration (FDA) has granted Priority Review to Chiesi Global Rare Diseases’ idebenone for Leber ...